| Biocept, UT Southwestern to study liquid biopsy platform in ALK-positive non-small cell lung cancer Healio The study also will evaluate patients with rare cancers, including anaplastic thyroid cancer, to determine if driver mutations such as ALK rearrangements can be identified and treated with targeted therapy to improve patient outcomes. "Identifying ALK ... |
from # All Medicine by Alexandros G. Sfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2uYLBIw
via IFTTT
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου
Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182,00306932607174,alsfakia@gmail.com,